CAMP - Camp4 Therapeutics Corp

Insider Purchase by 5Am Partners Vi, LLC (10%)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, 5Am Partners Vi, LLC, serving as 10% owner at Camp4 Therapeutics Corp (CAMP), purchased 2,941,176 shares at $1.53 per share, for a total transaction value of $4,499,999.00. Following this transaction, 5Am Partners Vi, LLC now holds 5,869,091 shares of CAMP.

This purchase represents a 100.00% increase in 5Am Partners Vi, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, September 11, 2025 and publicly disclosed via SEC Form 4 filing on Monday, September 15, 2025, 4 days after the trade was made.

Camp4 Therapeutics Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

5Am Partners Vi, LLC

10%

5AM Partners VI, LLC is the general partner of 5AM Ventures VI, L.P., a Delaware-incorporated limited partnership focused on early-stage life sciences investments, with its principal place of business at 501 Second Street, Suite 350, San Francisco, California.[[5]](https://www.sec.gov/Archives/edgar/data/1753037/000175303718000001/xslFormDX01/primary_doc.xml) As part of the broader 5AM Ventures ecosystem, founded in 2002 by former Bay City Capital principals, it supports seed and Series A investments in next-generation biopharmaceuticals, drug delivery technologies, and life science instruments through hands-on incubation via the 4:59 initiative.[[1]](https://growjo.com/company/5AM_Ventures)[[3]](https://5amventures.com)[[7]](https://radientanalytics.com/firm/form-d/5am-ventures-vi-l-p-1753037) 5AM Partners VI, LLC serves as a key entity in 5AM Ventures' operations, which include managing funds like the $450 million 5AM Ventures VII and extending to public equities via 5AM Opportunities II.[[3]](https://5amventures.com) Recently, it has been identified as a 10% owner in companies such as CinCor Pharma Inc (historically) and has traded as a corporate insider at Camp4 Therapeutics Corp (CAMP) at the 10% level.[[6]](https://www.gurufocus.com/insider/132044/5am-partners-vi,-llc) Leadership within 5AM Ventures includes founding partners like John Diekman and Scott Rocklage, alongside managing partners such as Andrew Schwab.[[1]](https://growjo.com/company/5AM_Ventures)[[2]](https://www.datanyze.com/companies/5am-ventures/197034906)

View full insider profile →

Trade Price

$1.53

Quantity

2,941,176

Total Value

$4,499,999.00

Shares Owned

5,869,091

Trade Date

Thursday, September 11, 2025

164 days ago

SEC Filing Date

Monday, September 15, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Camp4 Therapeutics Corp

Company Overview

No company information available
View news mentioning CAMP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/350721

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime